Business
BioElectronics' ActiPatch® Chronic Pain Therapy Featured In UK's Leading Daily Mail Newspaper Health Section
BioElectronics' ActiPatch® Chronic Pain Therapy Featured In UK's Leading Daily Mail Newspaper Health Section.
About this update from Bioelectronics Corp.
[{"type":"text","content":"\n\n\n\nBioElectronics' ActiPatch® Chronic Pain Therapy Featured In UK's Leading Daily Mail Newspaper Health Section\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nBioElectronics' ActiPatch® Chronic Pain Therapy Featured In UK's Leading Daily Mail Newspaper Health Section\nPR Newswire\nFREDERICK, Md., April 25, 2016\n\n\n\nFREDERICK, Md., April 25, 2016 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced nonprescription $30.00 neuromodulation pain management medical devices, announces that its ActiPatch® product's were featured in the United Kingdom's leading Daily Mail's Sunday Health Section, http://www.dailymail.co.uk/health/article-3555221/The-20-pulsing-skin-patch-end-misery-chronic-pain-arthritis-sufferers-diabetics.html. The paper has a circulation of 1.7 million and should increase the awareness of ActiPatch and its benefits for the millions of UK's chronic pain sufferers. \n\nThe article, entitled \"The £20 pulsing skin patch that could end the misery of chronic pain for arthritis sufferers and diabetics\" describes the devices unique technology and reports on the Company's new follow-up Observational Study. The 6-Month study of 254 men and women with different types of chronic pain suggest that it can be highly effective and lead to improved quality life and less dependence on strong painkillers. More than 90% had continued relief averaging a 61% reduction in pain, and nine out of ten had improved sleep. Some 89% were more physically active, 86% reduced their medication use, including prescription opioids, and 65% said they spent less money on over-the-counter painkillers. \n\nThe study has been accepted and will be presented at the British Pain Society annual scientific meeting being held from May 10-12 in Harrogate, UK https://www.britishpainsociety.org/2016-asm/. About BioElectronics Corporation\n\nBioElectronics Corporation is the maker of a leading family of affordable, disposable, drug-free, medical devices. ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskel...